Applicant, as named in the Orange Book

Upjohn

Next listed expiry: Lyrica Cr on 2 May 2027. 1 products with live protection, 11 without.

Products with listed protection

DrugEarliest generic entry
Lyrica Cr · 3 strengths
pregabalin
2 May 2027

Recent events

  • Lyrica · Generic approved · ANDA 218529, CaplinApproved 24 Feb 2026Detected 25 Oct 2026
  • Xalatan · Generic approved · ANDA 220360, Mankind PharmaApproved 17 Dec 2025Detected 25 Oct 2026
  • Lyrica · Generic approved · ANDA 219593, UnichemApproved 30 Apr 2026Detected 25 Oct 2026
  • Lipitor · Generic approved · ANDA 220276, Teva Pharms IncApproved 13 Nov 2025Detected 25 Oct 2026
  • Xanax · Generic approved · ANDA 213204, UnichemApproved 13 Jul 2026Detected 25 Oct 2026
  • Lyrica Cr · Enters 12-month window basis: patentListed date 2 May 2027Detected 24 Oct 2026
  • Lyrica Cr · Enters 12-month window basis: patentListed date 2 May 2027Detected 24 Oct 2026
  • Lyrica Cr · Enters 12-month window basis: patentListed date 2 May 2027Detected 24 Oct 2026
Products without listed protection (11)
DrugEarliest generic entry
Celebrex · 4 strengths
celecoxib
open now
Detrol · 2 strengths
tolterodine tartrate
open now
Effexor Xr · 3 strengths
venlafaxine hydrochloride
open now
Inspra · 2 strengths
eplerenone
open now
Lipitor · 4 strengths
atorvastatin calcium
open now
Lyrica
pregabalin
open now
Lyrica · 8 strengths
pregabalin
open now
Relpax · 2 strengths
eletriptan hydrobromide
open now
Xalatan
latanoprost
open now
Xanax · 4 strengths
alprazolam
open now
Xanax Xr · 4 strengths
alprazolam
open now